Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Triple Negative Breast Cancer Biomarker Study

This study has been completed.
Sponsor:
Collaborators:
Translational Drug Development
Life Technologies, Inc.
Information provided by (Responsible Party):
US Oncology Research
ClinicalTrials.gov Identifier:
NCT01111175
First received: April 22, 2010
Last updated: July 19, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)